1. Experimental Hematology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland;
2. Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia;
3. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany;
4. Center for Environmental and Systems Biochemistry, Department of Toxicology and Cancer Biology and Markey Cancer Center, University of Kentucky, Lexington, KY;
5. Biozentrum, University of Basel, Basel, Switzerland;
6. Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland;
7. Functional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland;
8. Immunobiology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland;
9. Department of Internal Medicine I, University of Bonn, Bonn, Germany;
10. European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain;
11. Department of Gastroenterology, Odense Hospital, University of Southern Denmark, Odense, Denmark;
12. Institute for Bioengineering of Catalonia, Barcelona, Spain;
13. Internal Medicine V, Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria;
14. Medical Clinic III for Oncology, Hematology, Immunoncology and Rheumatology, University Hospital Bonn, Bonn, Germany;
15. Institute of Veterinary Physiology, Vetsuisse Faculty and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland;
16. Institute of Pathology, University Hospital Basel, Basel, Switzerland;
17. Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany;
18. Department of Medicine, University of Cambridge, Cambridge, United Kingdom;
19. Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland; and
20. Institute for Medical Research, University of Belgrade, Belgrade, Serbia